The Mechanism of Uptake of Biodegradable Microparticles in Caco-2 Cells Is Size Dependent
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Purpose To study the uptake of biodegradable microparticles in Caco-2 cells.Methods Biodegradable microparticles of polylactic polyglycolic acid co-polymer (PLGA 50:50) of mean diameters 0.1 micron, 1 micron, and 10 microns containing bovine serum albumin as a model protein and 6-coumarin as a fluorescent marker were formulated by a multiple emulsion technique. The Caco-2 cell monolayers were incubated with each diameter microparticles (100 micrograms/ml) for two hours. The microparticle uptake in Caco-2 cells was studied by confocal microscopy and also by quantitating the 6-coumarin content of the microparticles taken up by the cells. The effects of microparticle concentration, and incubation time and temperature on microparticle cell uptake were also studied.Results The study demonstrated that the Caco-2 cell microparticle uptake significantly depends upon the microparticle diameter. The 0.1 micron diameter microparticles had 2.5 fold greater uptake on the weight basis than the 1 micron and 6 fold greater than the 10 microns diameter microparticles. Similarly in terms of number the uptake of 0.1 micron diameter microparticles was 2.7 x 10(3) fold greater than the 1 micron and 6.7 x 10(6) greater than the 10 microns diameter microparticles. The efficiency of uptake of 0.1 micron diameter microparticles at 100 micrograms/ml concentration was 41% compared to 15% and 6% for the 1 micron and the 10 microns diameter microparticles, respectively. The Caco-2 cell microparticle (0.1 micron) uptake increased with concentration in the range of 100 micrograms/ml to 500 micrograms/ml which then reached a plateau at higher concentration. The uptake of microparticles increased with incubation time, reaching a steady state at two hours. The uptake was greater at an incubation temperature of 37 degrees C compared to at 4 degrees C.Conclusions The Caco-2 cell microparticle uptake was microparticle diameter, concentration, and incubation time and temperature dependent. The small diameter microparticles (0.1 micron) had significantly greater uptake compared to larger diameter microparticles. The results thus suggest that the mechanism of uptake of microparticles in Caco-2 cell is particle diameter dependent. Caco-2 cells are used as an in vitro model for gastrointestinal uptake, and therefore the results obtained in these studies could be of significant importance in optimizing the microparticle-based oral drug delivery systems.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The capacity of transcytosis through the intestinal epithelial layer depends on the size, with a particle size of below 1 μm for optimal M-cell absorption [30], but also on the charge and hydrophilicity of the particle carrier [31–33].”
From Use of lectin-functionalized particles for oral immunotherapy (2012) · cites this paper as [32]
Citations
Cites
Artursson, P., & Karlsson, J. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91647-u · Cited by 1,893
Gastrointestinal Uptake of Biodegradable Microparticles: Effect of Particle Size
Desai, M. P., Labhasetwar, V., Amidon, G. L., & Levy, R. J. (1996) · Pharmaceutical Research · doi:10.1023/a:1016085108889 · Cited by 941
Self-citationArtursson, P. (1990) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600790604 · Cited by 844
Eldridge, J. H., Hammond, C. J., Meulbroek, J. A., Staas, J. K., Gilley, R. M., & Tice, T. R. (1990) · Journal of Controlled Release · doi:10.1016/0168-3659(90)90133-e · Cited by 689
Nano- and microparticles for the delivery of polypeptides and proteins
Couvreur, P., & Puisieux, F. (1993) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(93)90046-7 · Cited by 281
A Novel Approach to the Oral Delivery of Micro- or Nanoparticles
Bodmeier, R., Chen, H., & Paeratakul, O. (1989) · Pharmaceutical Research · doi:10.1023/a:1015987516796 · Cited by 276
Walter, E., Janich, S., Roessler, B. J., Hilfinger, J. M., & Amidon, G. L. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js960110x · Cited by 273
Self-citationThe Use of Cultured Epithelial and Endothelial Cells for Drug Transport and Metabolism Studies
Audus, K. L., Bartel, R. L., Hidalgo, I. J., & Borchardt, R. T. (1990) · Pharmaceutical Research · doi:10.1023/a:1015800312910 · Cited by 267
Nanoparticles as carriers for oral peptide absorption: Studies on particle uptake and fate
Florence, A. T., Hillery, A. M., Hussain, N., & Jani, P. U. (1995) · Journal of Controlled Release · doi:10.1016/0168-3659(95)00059-h · Cited by 260
Peroral administration of nanoparticles
Kreuter, J. (1991) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(91)90048-h · Cited by 207
Research works printed but not linked: 2
- J. Kreuter. J. Anat. 189:503–505, 1996.
- R. H. Muller. Colloidal Carriers for Controlled Drug Delivery and Targeting CRC Press, Boston, 1991.
Cited by
Determining the Size and Shape Dependence of Gold Nanoparticle Uptake into Mammalian Cells
Chithrani, B. D., Ghazani, A. A., & Chan, W. C. W. (2006) · Nano Letters · doi:10.1021/nl052396o · Cited by 4,879
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
Panyam, J., & Labhasetwar, V. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00228-4 · Cited by 3,361
Self-citationNanoparticle-based targeted drug delivery
Singh, R., & Lillard, J. W. (2009) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2008.12.004 · Cited by 2,734
“In general, the nanosize of these particles allows for efficient uptake by a variety of cell types and selective drug accumulation at target sites (Desai et al., 1997; Panyam and Labhasetwar, 2003; Panyam et al., 2003b).”
BackgroundInfluentialNonviral vectors for gene delivery
Mintzer, M. A., & Simanek, E. E. (2009) · Chemical Reviews · doi:10.1021/cr800409e · Cited by 2,366
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201403036 · Cited by 2,164
Nanocarriers’ entry into the cell: relevance to drug delivery
Hillaireau, H., & Couvreur, P. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0053-z · Cited by 1,552
“Cells from the gastrointestinal epithelium (Caco-2 cell line [91] as well as rat gastrointestinal tissue [92]) display a greater uptake for 100-nm PLGA particles compared to 500 nm–10 lm ones, both in terms of number and total mass.”
BackgroundFreeze-drying of nanoparticles: Formulation, process and storage considerations
ABDELWAHED, W., DEGOBERT, G., STAINMESSE, S., & FESSI, H. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.017 · Cited by 1,611
“These systems in general can be used to provide targeted (cellular/tissue) delivery of drugs, to improve oral bioavailability, to sustain drug effect in target tissue, to solubilize drugs for intravascular delivery, and to improve the stability of therapeutic agents against enzymatic degradation [6–9].”
BackgroundMohanraj, V. J., & Chen, Y. (2007) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v5i1.14634 · Cited by 1,217
Yin Win, K., & Feng, S.-S. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.07.050 · Cited by 1,452
Lee, K., Silva, E. A., & Mooney, D. J. (2011) · Journal of The Royal Society Interface · doi:10.1098/rsif.2010.0223 · Cited by 1,386
Applications of nanoparticle systems in drug delivery technology
Rizvi, S. A. A., & Saleh, A. M. (2018) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2017.10.012 · Cited by 1,334
Nanotech approaches to drug delivery and imaging
Sahoo, S. K., & Labhasetwar, V. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02903-9 · Cited by 1,203
Self-citationMechanics of receptor-mediated endocytosis
Gao, H., Shi, W., & Freund, L. B. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503879102 · Cited by 1,217
Food protein-based materials as nutraceutical delivery systems
Chen, L., Remondetto, G. E., & Subirade, M. (2006) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2005.12.011 · Cited by 1,160
Size‐Dependent Endocytosis of Nanoparticles
Zhang, S., Li, J., Lykotrafitis, G., Bao, G., & Suresh, S. (2009) · Advanced Materials · doi:10.1002/adma.200801393 · Cited by 1,059
Sahoo, S. K., Panyam, J., Prabha, S., & Labhasetwar, V. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00127-x · Cited by 990
Self-citationKulkarni, S. A., & Feng, S.-S. (2013) · Pharmaceutical Research · doi:10.1007/s11095-012-0958-3 · Cited by 768
“This also supports the claim by Desai (31).”
ResultNano-selenium and its nanomedicine applications: a critical review
Hosnedlova, B., Kepinska, M., Skalickova, S., Fernandez, C., Ruttkay-Nedecky, B., Peng, Q., Baron, M., Melcova, M., Opatrilova, R., Zidkova, J., et al. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s157541 · Cited by 630
“The nanosize of these materials allows an efficient uptake by various cell types and selective drug accumulation at target sites.(26) Like other chemotherapeutics, the effective cytotoxicity of nanomaterial-based drugs usually requires a high level of accumulation within the cancer cells.”
Jung, T. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00084-9 · Cited by 588
Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles
Prabha, S., Zhou, W.-Z., Panyam, J., & Labhasetwar, V. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00315-0 · Cited by 553
“Our studies and that of others have shown that the particle size significantly affects their cellular and tissue uptake ( Desai et al., 1997; Zauner et al., 2001), and in some cell lines, only the submicron size particles are taken up efficiently but not the larger size microparticles (e.g.”
ResultSelf-citationMittal, G., Sahana, D. K., Bhardwaj, V., & Ravi Kumar, M. N. V. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.01.016 · Cited by 551
“Larger particles are known to be readily taken up by the reticuloendothelial system (RES) cells (cells of liver and spleen) in the body [32,33].”
BackgroundPanyam, J., Dali, M. M., Sahoo, S. K., Ma, W., Chakravarthi, S. S., Amidon, G. L., Levy, R. J., & Labhasetwar, V. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00328-6 · Cited by 529
Self-citationCharacterization of nanoparticle uptake by endothelial cells
Davda, J., & Labhasetwar, V. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00923-1 · Cited by 524
“Caco-2) that the particle uptake depends on their size, with nanoparticles showing relatively greater efficacy of uptake than microparticles (Desai et al., 1997).”
BackgroundSelf-citationThe Intestinal Barrier and Current Techniques for the Assessment of Gut Permeability
Schoultz, I., & Keita, Å. V. (2020) · Cells · doi:10.3390/cells9081909 · Cited by 467
Is the oral route possible for peptide and protein drug delivery?
Morishita, M., & Peppas, N. A. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.08.005 · Cited by 515
Nanoparticles synthesis using supercritical fluid technology – towards biomedical applications
Byrappa, K., Ohara, S., & Adschiri, T. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.09.001 · Cited by 487
More Effective Nanomedicines through Particle Design
Wang, J., Byrne, J. D., Napier, M. E., & DeSimone, J. M. (2011) · Small · doi:10.1002/smll.201100442 · Cited by 466
Dong, Y., & Feng, S.-S. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2003.09.055 · Cited by 468
Chitosan and its derivatives in mucosal drug and vaccine delivery
van der Lubben, I. M., Verhoef, J. C., Borchard, G., & Junginger, H. E. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00172-5 · Cited by 456
Cellular Uptake of Elastic Nanoparticles
Yi, X., Shi, X., & Gao, H. (2011) · Physical Review Letters · doi:10.1103/physrevlett.107.098101 · Cited by 455
Silk proteins for biomedical applications: Bioengineering perspectives
Kundu, B., Kurland, N. E., Bano, S., Patra, C., Engel, F. B., Yadavalli, V. K., & Kundu, S. C. (2014) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2013.09.002 · Cited by 451
Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy
Raj, S., Khurana, S., Choudhari, R., Kesari, K. K., Kamal, M. A., Garg, N., Ruokolainen, J., Das, B. C., & Kumar, D. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.11.002 · Cited by 425
“It determines the in vivo distribution, bioavailability, biological fate, cellular toxicity, and targeted delivery through the nanosystem [16].”
BackgroundYin, L., Ding, J., He, C., Cui, L., Tang, C., & Yin, C. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.06.055 · Cited by 447
“Furthermore, the relatively larger particle sizes of TMC-Cys (500 kDa) NP might also be less preferable for cell uptake [28].”
BackgroundSilk fibroin nanoparticle as a novel drug delivery system
Mottaghitalab, F., Farokhi, M., Shokrgozar, M. A., Atyabi, F., & Hosseinkhani, H. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.03.020 · Cited by 444
Chitosan nanoparticles for oral drug and gene delivery
Bowman, K., & Leong, K. W. (2006) · International Journal of Nanomedicine · doi:10.2147/nano.2006.1.2.117 · Cited by 439
Microplastics Are Contaminants of Emerging Concern in Freshwater Environments: An Overview
Lambert, S., & Wagner, M. (2018) · The Handbook of Environmental Chemistry · doi:10.1007/978-3-319-61615-5_1 · Cited by 395
“[106] showed that 100 nm particles of a polylactic polyglycolic acid copolymer had a tenfold higher intracellular uptake in an in vitro cell culture when compared to 10 μm particles made of the same material.”
Current challenges in non-invasive insulin delivery systems: A comparative review
Khafagy, E.-S., Morishita, M., Onuki, Y., & Takayama, K. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.019 · Cited by 436
Controlled Growth Factor Delivery for Tissue Engineering
Tayalia, P., & Mooney, D. J. (2009) · Advanced Materials · doi:10.1002/adma.200900241 · Cited by 430
Zhang, Z., & Feng, S.-S. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.03.006 · Cited by 414
The uptake and intracellular fate of PLGA nanoparticles in epithelial cells
Cartiera, M. S., Johnson, K. M., Rajendran, V., Caplan, M. J., & Saltzman, W. M. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.01.057 · Cited by 412
“, vascular smooth muscle cells, Caco-2 cells) [15,31].”
Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs
Dong, Y., & Feng, S.-S. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.03.021 · Cited by 395
Feng, S.-S., & Chien, S. (2003) · Chemical Engineering Science · doi:10.1016/s0009-2509(03)00234-3 · Cited by 364
Behrens, I., Pena, A. I. V., Alonso, M. J., & Kissel, T. (2002) · Pharmaceutical Research · doi:10.1023/a:1019854327540 · Cited by 372
“71 g/mm(2) per monolayer) and the actual uptake, as described earlier (9).”
BackgroundInfluentialTeng, Z., Luo, Y., & Wang, Q. (2012) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf205238x · Cited by 357
Environmental exposure enhances the internalization of microplastic particles into cells
Ramsperger, A. F. R. M., Narayana, V. K. B., Gross, W., Mohanraj, J., Thelakkat, M., Greiner, A., Schmalz, H., Kress, H., & Laforsch, C. (2020) · Science Advances · doi:10.1126/sciadv.abd1211 · Cited by 347
Emerging Trends in Oral Delivery of Peptide and Protein Drugs
Mahato, R. I., Narang, A. S., Thoma, L., & Miller, D. D. (2003) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v20.i23.30 · Cited by 352
Hu, Y., Xie, J., Tong, Y. W., & Wang, C.-H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.11.028 · Cited by 351
“6% of the incorporated dye could leach out from the nanoparticles over 48 h under in vitro sink conditions [29], and coumarin-6 is a suitable marker for nanoparticles for studying the cellular uptake behavior [30].”
BackgroundHu, K., Li, J., Shen, Y., Lu, W., Gao, X., Zhang, Q., & Jiang, X. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.10.016 · Cited by 354
Transmucosal macromolecular drug delivery
Prego, C., García, M., Torres, D., & Alonso, M. J. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.07.030 · Cited by 338
“Indeed, at present, there is no doubt on the fact that the size is a critical parameter for the nanosystems to cross biological barriers [10,11].”
BackgroundSahoo, S. K., & Labhasetwar, V. (2005) · Molecular Pharmaceutics · doi:10.1021/mp050032z · Cited by 340
Self-citationTargeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy
Acharya, S., Dilnawaz, F., & Sahoo, S. K. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.07.008 · Cited by 333
Protein nanoparticle: A unique system as drug delivery vehicles
Jahanshahi, M., & Babaei, Z. (2008) · AFRICAN JOURNAL OF BIOTECHNOLOGY · doi:10.4314/ajb.v7i25.59701 · Cited by 314
“Different in vitro studies indicate that the particle size also influences the cellular uptake of nanoparticles (Desai et al., 1997; Zauner et al., 2001).”
BackgroundPanyam, J., Sahoo, S. K., Prabha, S., Bargar, T., & Labhasetwar, V. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00295-3 · Cited by 308
Self-citationAlginate Nanoparticles for Drug Delivery and Targeting
Severino, P., da Silva, C. F., Andrade, L. N., de Lima Oliveira, D., Campos, J., & Souto, E. B. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190425163424 · Cited by 304
Yu, J., Javier, D., Yaseen, M. A., Nitin, N., Richards-Kortum, R., Anvari, B., & Wong, M. S. (2010) · Journal of the American Chemical Society · doi:10.1021/ja908139y · Cited by 312
Gao, X., Tao, W., Lu, W., Zhang, Q., Zhang, Y., Jiang, X., & Fu, S. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.01.038 · Cited by 295
“4 PBS at 37 1C, which were consistent with previous studies [27], showed that no more than 5% and 4% of 6-coumarin was released from WGA-NP and unmodified nanoparticles, respectively, after a 24 h incubation period.”
MethodTargeting the brain with PEG–PLGA nanoparticles modified with phage-displayed peptides
Li, J., Feng, L., Fan, L., Zha, Y., Guo, L., Zhang, Q., Chen, J., Pang, Z., Wang, Y., Jiang, X., et al. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.03.031 · Cited by 296
Gutierro, I., Hernández, R. M., Igartua, M., Gascón, A. R., & Pedraz, J. L. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00435-8 · Cited by 292
Thiele, L., Rothen-Rutishauser, B., Jilek, S., Wunderli-Allenspach, H., Merkle, H. P., & Walter, E. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00412-6 · Cited by 281
Self-citationTortora, M., Cavalieri, F., Mosesso, P., Ciaffardini, F., Melone, F., & Crestini, C. (2014) · Biomacromolecules · doi:10.1021/bm500015j · Cited by 274
Polymeric nanoparticle drug delivery technologies for oral delivery applications
Pridgen, E. M., Alexis, F., & Farokhzad, O. C. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.1018175 · Cited by 269
“Studies of PLGA NPs in vitro with Caco2 cells (human adenocarcinoma cell line) and in vivo in rats revealed that uptake of 100 nm particles was more efficient than larger particles (500 nm, 1 μm, 10 μm) [85,86].”
Recent advancement of gelatin nanoparticles in drug and vaccine delivery
Sahoo, N., Sahoo, R. K., Biswas, N., Guha, A., & Kuotsu, K. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.08.006 · Cited by 270
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
Panyam, J., & Labhasetwar, V. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.023 · Cited by 270
Self-citationSahana, D. K., Mittal, G., Bhardwaj, V., & Kumar, M. N. V. R. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21158 · Cited by 260
PLGA Nanoparticles Formed by Single- or Double-emulsion with Vitamin E-TPGS
McCall, R. L., & Sirianni, R. W. (2013) · Journal of Visualized Experiments · doi:10.3791/51015 · Cited by 208
Hariharan, S., Bhardwaj, V., Bala, I., Sitterberg, J., Bakowsky, U., & Ravi Kumar, M. N. V. (2006) · Pharmaceutical Research · doi:10.1007/s11095-005-8418-y · Cited by 257
“Larger particles are known to be readily taken up by the reticuloendothelial system (RES) cells (cells of liver and spleen) (32,29).”
BackgroundNano-formulations of drugs: Recent developments, impact and challenges
Jeevanandam, J., Chan, Y. S., & Danquah, M. K. (2016) · Biochimie · doi:10.1016/j.biochi.2016.07.008 · Cited by 244
Modulation of the Cellular Uptake of DNA Origami through Control over Mass and Shape
Bastings, M. M. C., Anastassacos, F. M., Ponnuswamy, N., Leifer, F. G., Cuneo, G., Lin, C., Ingber, D. E., Ryu, J. H., & Shih, W. M. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b00660 · Cited by 249
Ecotoxicological and regulatory aspects of environmental sustainability of nanopesticides
Grillo, R., Fraceto, L. F., Amorim, M. J. B., Scott-Fordsmand, J. J., Schoonjans, R., & Chaudhry, Q. (2021) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2020.124148 · Cited by 243
Luo, Y., Zhang, B., Cheng, W.-H., & Wang, Q. (2010) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2010.06.029 · Cited by 247
Biodegradable, polymeric nanoparticle delivery systems for cancer therapy
Pridgen, E. M., Langer, R., & Farokhzad, O. C. (2007) · Nanomedicine · doi:10.2217/17435889.2.5.669 · Cited by 249
“The small size of nanoparticles confers several advantages, including increased intracellular uptake [8,9] and access to tissues in which larger particles are excluded [10].”
BackgroundRecent Advances in Drug Delivery Systems
Martinho, N., Damgé, C., & Reis, C. P. (2011) · Journal of Biomaterials and Nanobiotechnology · doi:10.4236/jbnb.2011.225062 · Cited by 244
“15%) [17].”
The effect of poloxamer 188 on nanoparticle morphology, size, cancer cell uptake, and cytotoxicity
Yan, F., Zhang, C., Zheng, Y., Mei, L., Tang, L., Song, C., Sun, H., & Huang, L. (2010) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2009.05.004 · Cited by 238
Intracellular Drug Delivery by Poly(lactic-co-glycolic acid) Nanoparticles, Revisited
Xu, P., Gullotti, E., Tong, L., Highley, C. B., Errabelli, D. R., Hasan, T., Cheng, J.-X., Kohane, D. S., & Yeo, Y. (2009) · Molecular Pharmaceutics · doi:10.1021/mp800137z · Cited by 234
Nanotechnology as Emerging Tool for Enhancing Solubility of Poorly Water-Soluble Drugs
Kumar, S., Dilbaghi, N., Saharan, R., & Bhanjana, G. (2012) · BioNanoScience · doi:10.1007/s12668-012-0060-7 · Cited by 227
Walter, E., Dreher, D., Kok, M., Thiele, L., Kiama, S. G., Gehr, P., & Merkle, H. P. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00413-8 · Cited by 230
Self-citationQaddoumi, M. G., Ueda, H., Yang, J., Davda, J., Labhasetwar, V., & Lee, V. H. L. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000022411.47059.76 · Cited by 229
“(16) showing that Caco-2 cells uptake of PLGA microparticles was time-, size-, and concentration-dependent.”
BackgroundSelf-citationChitosan/cyclodextrin nanoparticles as macromolecular drug delivery system
KRAULAND, A., & ALONSO, M. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.03.005 · Cited by 222
Nuclear penetration of surface functionalized gold nanoparticles
Gu, Y.-J., Cheng, J., Lin, C.-C., Lam, Y. W., Cheng, S. H., & Wong, W.-T. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.03.009 · Cited by 216
Pillay, V., & Fassihi, R. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00197-7 · Cited by 217
Lipid Nanoparticles: Effect on Bioavailability and Pharmacokinetic Changes
Souto, E. B., & Müller, R. H. (2010) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-00477-3_4 · Cited by 210
Nanoparticles of biodegradable polymers for new-concept chemotherapy
Feng, S.-S. (2004) · Expert Review of Medical Devices · doi:10.1586/17434440.1.1.115 · Cited by 206
Zhang, J., Liang, L., Tian, Z., Chen, L., & Subirade, M. (2012) · Food Chemistry · doi:10.1016/j.foodchem.2012.01.049 · Cited by 200
Variable Nanoparticle-Cell Adhesion Strength Regulates Cellular Uptake
Yuan, H., Li, J., Bao, G., & Zhang, S. (2010) · Physical Review Letters · doi:10.1103/physrevlett.105.138101 · Cited by 200
Surface-engineered nanoparticles for multiple ligand coupling
Gref, R., Couvreur, P., Barratt, G., & Mysiakine, E. (2003) · Biomaterials · doi:10.1016/s0142-9612(03)00348-x · Cited by 197
Panyam, J., & Labhasetwar, V. (2004) · Molecular Pharmaceutics · doi:10.1021/mp034002c · Cited by 195
Self-citationFerrari, R., Sponchioni, M., Morbidelli, M., & Moscatelli, D. (2018) · Nanoscale · doi:10.1039/c8nr05933k · Cited by 189
Arya, N., Chakraborty, S., Dube, N., & Katti, D. S. (2009) · Journal of Biomedical Materials Research Part B: Applied Biomaterials · doi:10.1002/jbm.b.31085 · Cited by 192
“Because of their size, drug carrying micro/nanoparticles can be internalized by cells thereby allowing for easy transport of the bioactive agent across the cell membrane.(1) With the use of small sized particles, it is possible to administer bioactive agents in a controlled manner using less invasive means such as inj…”
BackgroundOral delivery of proteins by biodegradable nanoparticles
Bakhru, S. H., Furtado, S., Morello, A. P., & Mathiowitz, E. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.04.006 · Cited by 190
Effect of particle agglomeration in nanotoxicology
Bruinink, A., Wang, J., & Wick, P. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1460-6 · Cited by 181
“2010); Caco-2 cells: ≤10 μm (Desai et al. 1997)).”
BackgroundInfluentialEffectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs
Takeuchi, H., Matsui, Y., Sugihara, H., Yamamoto, H., & Kawashima, Y. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.06.028 · Cited by 190
Recent advances in nanoparticle-mediated drug delivery
Kumar, B., Jalodia, K., Kumar, P., & Gautam, H. K. (2017) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2017.07.019 · Cited by 187
Past, Present, and Future Technologies for Oral Delivery of Therapeutic Proteins
Singh, R., Singh, S., & Lillard, J. W. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21183 · Cited by 186
Kämpfer, A. A. M., Urbán, P., Gioria, S., Kanase, N., Stone, V., & Kinsner-Ovaskainen, A. (2017) · Toxicology in Vitro · doi:10.1016/j.tiv.2017.08.011 · Cited by 175
“For decades, in vitro models of the intestine have been used to study the pharmacological and toxicological effects, as well as the bio-availability of substances (Sambruy et al., 2001) and materials (Desai et al., 1997).”
BackgroundNanoparticles in relation to peptide and protein aggregation
Khan, R., Ahmad, E., Zaman, M., Qadeer, A., & Rabbani, G. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s54171 · Cited by 180
Leary, S. P., Liu, C. Y., & Apuzzo, M. L. J. (2006) · Neurosurgery · doi:10.1227/01.neu.0000217016.79256.16 · Cited by 184
“First, their small size allows penetration through smaller capillaries, leading to increased accumulation of the drug at the target site (25, 103).”
BackgroundTSAI, M., BAI, S., & CHEN, R. (2008) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2007.06.015 · Cited by 177
Sayın, B., Somavarapu, S., Li, X. W., Thanou, M., Sesardic, D., Alpar, H. O., & Şenel, S. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.06.029 · Cited by 178
Liu, H., Liu, T., Wu, X., Li, L., Tan, L., Chen, D., & Tang, F. (2012) · Advanced Materials · doi:10.1002/adma.201103343 · Cited by 178
Krebs, M. D., Salter, E., Chen, E., Sutter, K. A., & Alsberg, E. (2010) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.32441 · Cited by 176
Metadata
- Authors
- Desai, M. P., Labhasetwar, V., Walter, E., Levy, R. J., & Amidon, G. L.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Amidon, Gordon L.
- Venue
- Pharmaceutical Research
- Published
- 1997-11
- Volume
- 14
- Issue
- 11
- Pages
- 1568-1573
- ISSN
- 0724-8741 (ISSN-L)
- 1573-904X
- OpenAlex
- W1664986234
- Cited by
- 858
- References
- 33
- Citations by year
- 2026: 5 · 2025: 22 · 2024: 20 · 2023: 16 · 2022: 38 · 2021: 22 · 2020: 43 · 2019: 34 · 2018: 25 · 2017: 42 · 2016: 46 · 2015: 41 · 2014: 59 · 2013: 45 · 2012: 62
- FWCI
- 6.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Pharmaceutical Research (publishedVersion)
- PubMed (publishedVersion)
- Deep Blue (University of Michigan) (submittedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Keywords
- Caco-2 cells, biodegradable microparticles, PLGA, microparticle size, intestinal absorption, bovine serum albumin, multiple emulsions, temperature dependence, concentration dependence, incubation time, intestinal epithelial cells, drug delivery systems, oral bioavailability prediction
- MeSH terms
- Polylactic Acid-Polyglycolic Acid Copolymer, Animals, Cattle, Cell Membrane Permeability, Humans, Intestinal Absorption, Microspheres, Models, Biological, Particle Size, Polyglycolic Acid, Polymers, Serum Albumin, Bovine, Microscopy, Confocal, Caco-2 Cells, Lactic Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.